Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Best Dividend Stocks
Ex-Dividend Dates
High Yield Stocks
Screener
Strategies
Tools
Articles
Premium
Advisors

Pfizer stock logo

News

The Last Chapter in a Big Pfizer Plan

Evan Cooper Sep 29, 2016


The news from Pfizer Inc. (PFE ) at the end of last November landed like a bomb.

The New York-based pharmaceutical giant announced that it would buy Botox manufacturer Allergan Plc (AGN ) in a deal worth $160 billion, making the combined company the largest drugmaker in the world.

A Complex Merger

However, the size of the deal – or even the size of the new corporate behemoth – wasn’t what made it notable. The acquisition involved a complicated legal dance in which Allergan would technically buy Pfizer and the company’s headquarters would be moved to Ireland, even though the new company would actually be run by Pfizer executives in New York.

To read the Full Story, Go Premium or Log in

Popular Articles